Consistent with the “incessant ovulation” hypothesis of ovarian cancer pathogenesis, a decreased risk of ovarian cancer has been demonstrated in the BRCA1/2 mutated [65] and general populations [66] who have used oral contraceptives. This evidence concerns the gene BRCA1 and ovarian carcinoma.